Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-25 @ 4:12 AM
NCT ID:
NCT00267020
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of adenocarcinoma of the pancreas.
* Pretreatment tumor specimen must be available.
* No prior chemotherapy immunotherapy, biological therapy, or hormonal therapy for pancreatic cancer, including 5-fluorouracil (5-FU) with radiation therapy.
* Prior radiation allowed.
* Ability to stop some types of anti-seizure medicines within 14 days of enrollment.
Exclusion Criteria:
* Endocrine pancreatic tumor or ampullary cancer.
* Central Nervous System (CNS) metastases.
* Inability to swallow tablets.
* 10% or greater weight loss over the 6 weeks before study entry.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00267020
Study Brief:
Protocol Section:
NCT00267020